ArticleProceedings of the National Academy of Sciences of the United States of America2023

Loss of PPARγ activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunity.

Joseph A Caruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.